Plaintiff
Defendant
- Parties: The plaintiffs were Bayer Inc and Regeneron Pharmaceuticals, Inc. The defendant was Amgen Canada Inc.
- Subject Matter: This action involved the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Jan. 19, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Court
Federal CourtCase Number
T-1921-23Practice Area
Intellectual propertyAmount
Winner
Trial Start Date
14 September 2023Download documents